Abstract
In this paper, we examine the association between polymorphisms of the angiotensin-converting enzyme (ACE) and muscle-specific creatine kinase (CKMM) genes, and the actual performance status observed in professional cyclists capable of completing a classic tour stage race such as the Giro d'Italia, Tour de France, or Vuelta a España. To accomplish this, we compared the frequencies of the ACE and CKMM genotypes/alleles in 50 top-level Spanish professional cyclists that have completed at least one of these events to 119 sedentary controls, and 27 elite (Olympic-class) Spanish runners. The genetic polymorphism at the CK-MM locus was detected with the NcoI restriction endonuclease. The results of our study showed that the proportion of the DD genotype was higher in cyclists (50.0 %) than in the other two groups (p < 0.05), the proportion of the ID genotype was higher in controls (46.2 %) than in the other two groups (p < 0.05), and the proportion of the II genotype was higher in runners (40.7 %) than in the other two groups (p < 0.05). The proportion of the D allele was higher in both cyclists (65.0 %) and controls (57.6 %) than in runners (46.3 %) (p < 0.001), whereas the proportion of the I allele was higher in runners than in the other two groups (p < 0.001). No statistical differences were found for CKK-MM-NcoI. We conclude that in top-level professional cyclists capable of completing a classic 3-wk tour race, the frequency distribution of the D allele and the DD genotype seems to be higher than in other endurance athletes such as elite runners (in whom the I allele is especially frequent).
Key words
Genotype - allele - sports - endurance
References
1
Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero J R, Batalla A, Cortina A, Fernández-García B, Rodríguez C, Braga S, Alvarez V, Coto E.
Genetic variation in the renin-angiotensin system and athletic performance.
Eur J Appl Physiol.
2000;
82
117-120
2
Bassett D R, Howley E T.
Limiting factors for maximum oxygen uptake and determinants of endurance performance.
Med Sci Sports Exerc.
2000;
32
70-84
3
Coetzer P, Noakes T D, Sanders B, Lambert M I, Bosch A N, Wiggins T, Dennis S C.
Superior resistance of elite black South African distance runners.
J Appl Physiol.
1993;
75
1822-1827
4
Coyle E F, Sidossis L F, Horowitz J F, Beltz J D.
Cycling efficiency is related to the percentage of Type I muscle fibers.
Med Sci Sports Exerc.
1992;
24
782-788
5
Echegaray M, Rivera M A.
Role of creatine kinase isoenzymes on muscular and cardiorespiratory endurance. Genetic and molecular evidence.
Sports Med.
2001;
31
919-934
6
Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermayer D S, Trent R J.
Elite endurance athletes and the ACE I allele -the role of genes in athletic performance.
Hum Genet.
1998;
103
48-50
7
Gennarelli M, Novelli G, Cobo A, Baiget M, Dallapiccola B.
3′creatine kinase (M-type) polymorphisms linked to myotonic dystrophy in Italian and Spanish populations.
Hum Genet.
1991;
87
654-656
8
Giner V, Corella D, Chaves F J, Pascual J M, Portolés O, Marín P, Lozano J V, Armengold M E, Redón J.
Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish population.
Med Clin (Barc).
2001;
117
525-529
9
Hunley T E, Julian B A, Phillips 3rd J A.
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Kidney Int.
1996;
49
571-577
10
Jones A, Montgomery H E, Woods D R.
Human performance: a role for the ACE genotype?.
Exerc Sport Sci Rev.
2002;
30
184-190
11
Jones A, Woods D R.
Skeletal muscle RAS and exercise performance.
Int J Biochem Cell Biol.
2003;
35
855-866
12
Larsen H B.
Kenyan dominance in distance running.
Comp Biochem Physiol A Mol Integr Physiol.
2003;
136
161-170
13
Lindpaintner K, Pfeffer M A, Kreutz R, Stampfer M J, Grodstein F, LaMotte F, Buring J, Hennekens C H.
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.
N Engl J Med.
1995;
332
706-711
14
Lucia A, Díaz B, Hoyos J, Fernández C, Villa G, Bandres F, Chicharro J L.
Hormone levels of world class cyclists during the Tour of Spain stage race.
Br J Sports Med.
2001;
35
424-430
15
Lucia A, Earnest C, Arribas C.
The Tour de France: a physiological review.
Scand J Med Sci Sport.
2003;
13
275-283
16
Lucia A, Hoyos J, Carvajal A, Chicharro J L.
Heart rate response to professional road cycling: the Tour de France.
Int J Sports Med.
1999;
20
167-172
17
Lucia A, Hoyos J, Chicharro J L.
Physiology of professional road cycling.
Sports Med.
2001;
31
325-337
18
Lucia A, Hoyos J, Pérez M, Santalla A, Chicharro J L.
Inverse relationship between V·O2 max and economy/efficiency in world-class cyclists.
Med Sci Sports Exerc.
2002;
34
2079-2084
19
Lucia A, Hoyos J, Santalla A, Earnest C, Chicharro J L.
Tour de France vs. Vuelta a España: Which is harder?.
Med Sci Sports Exerc.
2003;
35
872-878
20
Mondorf U F, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T.
Contribution of angiotensin I converting enzyme gene polymorphism and angiotensin gene polymorphism to blood pressure regulation in essential hypertension.
Am J Hypertens.
1998;
11
174-183
21
Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H.
Human angiotensin I-converting enzyme gene and endurance performance.
J Appl Physiol.
1999;
87
1313-1316
22
Nazarov I B, Woods D R, Montgomery H E, Shneider O V, Kazakov V I, Tomilin N V, Rogozkin V A.
The angiotensin converting enzyme I/D polymorphism in Russian athletes.
Eur J Hum Genet.
2001;
9
797-801
23
Noakes T D.
Implications of exercise testing for prediction of athletic performance: A contemporary perspective.
Med Sci Sports Exerc.
1988;
20
319-330
24
Rankinen T, Wolfarth B, Simoneau J-A, Maier L-D, Rauramaa R, Rivera M A, Boulay M R, Chagnon Y C, Pérusse L, Keul J, Bouchard C.
No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status.
J Appl Physiol.
2000;
88
1571-1575
25
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F.
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
J Clin Invest.
1990;
86
1343-1346
26
Rivera M A, Dionne F T, Simoneau J A, Pérusse L, Chagnon M, Chagnon Y, Gagnon J, Leon A S, Rao D C, Skinner J S, Wilmore J H, Bouchard C.
Muscle-specific creatine kinase gene polymorphism and VO2max in the HERITAGE Family Study.
Med Sci Sports Exerc.
1997;
29
1311-1317
27
Rivera M A, Dionne F T, Wolfarth B, Chagnon M, Simoneau J-A, Pérusse L, Boulay M R, Gagnon J, Song T MK, Keul J, Bouchard C.
Muscle-specific creatine kinase gene polymorphisms in elite endurance athletes and sedentary controls.
Med Sci Sports Exerc.
1997;
29
1444-1447
28
Rivera M A, Pérusse L, Simoneau J A, Gagnon J, Dionne F T, Leon A S, Skinner J S, Wilmore J H, Province M, Rao D C, Bouchard C.
Linkage between muscle-specific CK gene markers and VO2max in the HERITAGE Family Study.
Med Sci Sports Exerc.
1999;
31
698-701
29
Scanavini D, Bernardi F, Castoldi E, Conconi F, Mazzoni G.
Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes.
Eur J Hum Genet.
2002;
10
576-577
30
Taylor R R, Mamotte C D, Fallon K, van Bockxmeer F M.
Elite athletes and the gene for angiotensin-converting enzyme.
J Appl Physiol.
1999;
87
1035-1037
31
Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, Jones A, Humphries S, Montgomery H.
Elite swimmers and the D allele of the ACE I/D polymorphism.
Hum Genet.
2001;
108
230-232
32
Yamashita K, Yoshioka T.
Profiles of creatine kinase isoenzyme compositions in single muscle fibers of different types.
J Muscle Res Cell Motil.
1991;
12
37-44
MD PhD Alejandro Lucía
Universidad Europea de Madrid
28670 Villaviciosa de Odón
Madrid
Spain
Fax: + 34 9 16 16 82 65
Email: alejandro.lucia@mrfs.cisa.uem.es